Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intervention for adult metabolic syndrome in the Beijing region
ChiCTR-TRC-08000111Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pioglitazone and metformin in cardiometabolic risk (CMR) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoints: Incidence of cardiocerebrovascular events and All-cause mortality. Started Jun 2008; status: recruiting.
02
Drugs
pioglitazonemetformin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR-TRC-08000111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000111.